Effectiveness and Safety of Standard- and Low-Dose Rivaroxaban in Asians With Atrial Fibrillation - ScienceDirect
Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial - The Lancet
Aspirin and an oral anticoagulant – can they be used together? - NPS MedicineWise
Xarelto® - Responsible Use
Transitioning Between Anticoagulants Continuous Infusion Unfractionated Heparin (UFH) SC LMWH or Fondaparinux Rivaroxaban (Xarel
Guidance on Converting Between Anticoagulants
Bridging the Gap: How to Transition from the NOACs to Warfarin - PDF Free Download
Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons | The BMJ
Apixaban starting dose after 1 week LMWH therapy (PE or DVT)? | ResearchGate
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
New Oral Anticoagulants: A Review - ppt video online download
Anticoagulation Strategies in Patients With Cancer: JACC Review Topic of the Week - ScienceDirect
Guidance on converting between anticoagulants
Safety Profile - DVT & PE Initial Treatment | XARELTO® (rivaroxaban) HCP
Updated Guidelines on Outpatient Anticoagulation | AAFP
Transition of Anticoagulants 2016
Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges | Journal of the American Heart Association
Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials -
Pharmacokinetic and pharmacodynamic evaluation of rivaroxaban: considerations for the treatment of venous thromboembolism | Thrombosis Journal | Full Text
Time for a change? Switching anticoagulants in patients with AF or VTE | Thrombosis Adviser
Antithrombotic Management of Venous Thromboembolism: JACC Focus Seminar - ScienceDirect
Xarelto® Rivaroxaban The first oral direct factor Xa inhibitor - ppt download
Dose of XARELTO for Switching From Another Anticoagulant During Initial DVT or PE Treatment
Recommendations for Switching to and From Rivaroxaban 9 | Download Table
